MeSH Browser

MeSH Heading: Fluorodeoxyglucose F18
Tree Number(s): D09.254.229.500
Unique ID: D019788
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D019788
Scope Note: The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY for the assessment of cerebral and myocardial glucose metabolism in various physiological or pathological states including stroke and myocardial ischemia. It is also employed for the detection of malignant tumors including those of the brain, liver, and thyroid gland. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1162)
Entry Term(s): 18F Fluorodeoxyglucose; 18F-FDG; 18FDG; 2-Fluoro-2-deoxy-D-glucose; 2-Fluoro-2-deoxyglucose; Fludeoxyglucose F 18; Fluorine-18-fluorodeoxyglucose; Fluorodeoxyglucose F 18
Pharm Action: Radiopharmaceuticals
Registry Numbers: 0Z5B2CJX4D; 0
Related Numbers: 29702-43-0; 63503-12-8; 83903-67-7
Previous Indexing: Deoxyglucose/analogs & derivatives (1978-1997)
Public MeSH Note: 2005; see FLUDEOXYGLUCOSE F 18 1998-2004; FLUDEOXYGLUCOSE F 18 was indexed under DEOXYGLUCOSE/analogs & derivatives 1978-1997
History Note: 2005(1978)
Date Established: 1998/01/01
Date of Entry: 1997/06/20
Revision Date: 2019/07/01

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Concept UI: M0029360
Registry Numbers: 0Z5B2CJX4D
Related Numbers: 29702-43-0; 63503-12-8; 83903-67-7
Scope Note: The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY for the assessment of cerebral and myocardial glucose metabolism in various physiological or pathological states including stroke and myocardial ischemia. It is also employed for the detection of malignant tumors including those of the brain, liver, and thyroid gland. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1162)
Terms: Fluorodeoxyglucose F18 Preferred Term
Term UI T577504
Date03/17/2004
LexicalTag NON
ThesaurusID NLM (2005); 18F Fluorodeoxyglucose
Term UI T058843
Date01/28/1997
LexicalTag NON
ThesaurusID NLM (1998); 18F-FDG
Term UI T058842
Date01/28/1997
LexicalTag ABB
ThesaurusID; 18FDG
Term UI T058844
Date01/09/1997
LexicalTag ABB
ThesaurusID NLM (1998); Fludeoxyglucose F 18
Term UI T058840
Date01/01/1999
LexicalTag ABX
ThesaurusID; Fluorine-18-fluorodeoxyglucose
Term UI T058841
Date01/28/1997
LexicalTag NON
ThesaurusID NLM (1998); Fluorodeoxyglucose F 18
Term UI T577505
Date03/17/2004
LexicalTag NON
ThesaurusID NLM (2005)

Fluorodeoxyglucose F18 MeSH Descriptor Data 2025